Leucine, an AI-driven pharmaceutical manufacturing firm based in New York, has secured $7 million in a Series A funding round. The investment was spearheaded by Ecolab, garnering support from prior investors such as Pravega Ventures, Axilor Ventures, Techstars, and several angel investors. This new capital infusion aims to enhance Leucine's AI capabilities, transforming its AI Co-pilot into an essential tool for pharmaceutical production processes.